Acute and chronic treatment with moclobemide, a reversible MAO-inhibitor, potentiates the antielectroshock activity of conventional antiepileptic drugs in mice

Banach, 2016, Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities, Expert Opin. Drug Metab. Toxicol., 12, 1067, 10.1080/17425255.2016.1198319 Boissier, 1960, Une nouvelle methode simple pour explorer l’action tranquilisante: le test de la cheminee, Med. Exp. (Basel), 3, 81, 10.1159/000134913 Bonnet, 2002, Moclobemide: evolution, pharmacodynamic and pharmacokinetic properties, CNS Drug Rev., 8, 283, 10.1111/j.1527-3458.2002.tb00229.x Bonnet, 2003, Moclobemide: therapeutic use and clinical studies, CNS Drug Rev., 9, 97, 10.1111/j.1527-3458.2003.tb00245.x Borowicz, 2002, Effects of tamoxifen, mifepristone and cyproterone on the electroconvulsive threshold and pentetrazole-induced convulsions in mice, Pol. J. Pharmacol., 54, 103 Borowicz, 2006, Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice, Pharmacol. Rep., 58, 83 Borowicz, 2007, Acute and chronic treatment with mianserin differentially affects the anticonvulsant activity of conventional antiepileptics drugs in the mouse maximal electroshock model, Psychopharmacology, 195, 167, 10.1007/s00213-007-0878-9 Borowicz, 2007, Chronically administered fluoxetine enhances the anticonvulsant activity of conventional antiepileptics drugs in the mouse maximal electroshock model, Eur. J. Pharmacol., 567, 77, 10.1016/j.ejphar.2007.03.015 Borowicz, 2010, Effect of acute and chronic treatment with milnacipran potentiates the anticonvulsant activity of conventional antiepileptic drugs in the maximal electroshock-induced seizures in mice, Psychopharmacology, 207, 661, 10.1007/s00213-009-1698-x Borowicz, 2011, Effect of acutely and chronically administered venlafaxine on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock model, Eur. J. Pharmacol., 670, 114, 10.1016/j.ejphar.2011.08.042 Borowicz, 2012, Trazodone reduces the anticonvulsant action of certain classical antiepileptics in the mouse maximal electroshock model, Pharmacol. Rep., 64, 1136, 10.1016/S1734-1140(12)70910-6 Borowicz, 2014, Reboxetine and its influence on the action of classical antiepileptic drugs in the mouse maximal electroshock model, Pharmacol. Rep., 66, 430, 10.1016/j.pharep.2013.11.009 Castel-Branco, 2009, The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drug, Methods Find. Exp. Clin. Pharmacol., 31, 101, 10.1358/mf.2009.31.2.1338414 Chu, 2013, Species differences in drug transporters and implications for translating preclinical findings to humans, Expert Opin. Drug Metab. Toxicol., 9, 237, 10.1517/17425255.2013.741589 Deak, 2000, Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells, Neuropharmacology, 39, 1029, 10.1016/S0028-3908(99)00206-3 Ghasemi, 2018, Mechanisms underlying anticonvulsant and proconvulsant actions of norepinephrine, Neuropharmacology, 137, 297, 10.1016/j.neuropharm.2018.05.015 Jobe, 2003, Common pathogenic mechanisms between depression and epilepsy: an experimental perspective, Epilepsy Behav., 4, S14, 10.1016/j.yebeh.2003.08.020 Jobe, 2005, The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant, Epilepsy Behav., 7, 602, 10.1016/j.yebeh.2005.07.014 Jobe, 1999, A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders, Crit. Rev. Neurobiol., 13, 317, 10.1615/CritRevNeurobiol.v13.i4.10 Li, 2019, Comparison of kainate-induced seizures, cognitive impairment and hippocampal damage in male and female mice, Life Sci., 232, 116621, 10.1016/j.lfs.2019.116621 Litchfield, 1949, A simplified method of evaluating dose-effect experiments, J. Pharmacol. Exp. Ther., 96, 99 Löscher, 2011, Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs, Seizure, 20, 359, 10.1016/j.seizure.2011.01.003 Löscher, 1991, The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models, Epilepsy Res., 8, 79, 10.1016/0920-1211(91)90075-Q Pottoo, 2019, Estrogen and serotonin: complexity of interactions and implications for epileptic seizures and epileptogenesis, Curr. Neuropharmacol., 17, 214, 10.2174/1570159X16666180628164432 Rakic Ignjatovic, 2009, Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study, Br. J. Clin. Pharmacol., 67, 199, 10.1111/j.1365-2125.2008.03326.x Salzberg, 2001, Epilepsy, depression and antidepressant drugs, J. Clin. Neurosci., 8, 209, 10.1054/jocn.2000.0896 Scharfman, 2014, Sex differences in neurobiology of epilepsy: a preclinical perspective, Neurobiol. Dis., 72, 180, 10.1016/j.nbd.2014.07.004 Ugale, 2004, Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice, Brain Res., 1023, 102, 10.1016/j.brainres.2004.07.018 Uzbay, 2008, Serotonergic anti-depressants and ethanol withdrawal syndrome: a review, Alcohol Alcohol., 43, 15, 10.1093/alcalc/agm145 Venault, 1986, Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks, Nature, 321, 864, 10.1038/321864a0 Wahnschaffe, 1992, Lack of changes in seizure susceptibility during the estrous cycle in kindled rats, Epilepsy Res., 13, 199, 10.1016/0920-1211(92)90053-V Zemlan, 1990, Depression and antidepressant therapy: receptor dynamics, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 14, 503, 10.1016/0278-5846(90)90004-Z